Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 157 articles:
HTML format



Single Articles


    March 2021
  1. NANNA MG, Newby LK
    In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed     Abstract available


  2. BATES ER
    In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
    Ann Intern Med. 2021;174:JC30.
    PubMed     Abstract available


  3. GIANNASI G, Nanni V, Nucci A, Perini AP, et al
    Acute ST-Segment Elevation From an Ingested Battery: A Case Report.
    Ann Intern Med. 2021;174:425-426.
    PubMed    


    January 2021
  4. COHN JN
    Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/ACPJ202101190.
    PubMed     Abstract available


    December 2020
  5. HICKS CW, Wang D, Matsushita K, Windham BG, et al
    Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.
    Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-1340.
    PubMed     Abstract available


    October 2020
  6. BAVISHI C
    In ACS treated with drug-eluting stents and 3 mo of DAPT, ticagrelor monotherapy reduced clinical events at 1 y vs. DAPT.
    Ann Intern Med. 2020;173:JC43.
    PubMed     Abstract available


  7. NANNA MG, Granger CB
    In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.
    Ann Intern Med. 2020;173:JC44.
    PubMed     Abstract available


    September 2020
  8. RESTON JT, Buelt A, Donahue MP, Neubauer B, et al
    Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4680.
    PubMed     Abstract available


  9. O'MALLEY PG, Arnold MJ, Kelley C, Spacek L, et al
    Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4648.
    PubMed     Abstract available


  10. KELSEY MD, Newby LK
    In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year.
    Ann Intern Med. 2020;173:JC28.
    PubMed     Abstract available


  11. HOFFER EP
    In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo.
    Ann Intern Med. 2020;173:JC29.
    PubMed     Abstract available


  12. ELGENDY IY
    In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding.
    Ann Intern Med. 2020;173:JC27.
    PubMed     Abstract available


  13. D'ANCI KE, Tipton K, Hedden-Gross A, Rouse B, et al
    Effect of Intensive Blood Pressure Lowering on Cardiovascular Outcomes: A Systematic Review Prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-2037.
    PubMed     Abstract available


    August 2020
  14. MACINTYRE CR
    Influenza Vaccine: Routine Secondary Prevention for Patients With Cardiovascular Disease?
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-5810.
    PubMed    


  15. CHOW EJ, Rolfes MA, O'Halloran A, Anderson EJ, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-1509.
    PubMed     Abstract available


  16. BATES ER
    In stable coronary disease with moderate or severe ischemia, initial invasive therapy plus medical therapy did not improve CV outcomes at 3 years.
    Ann Intern Med. 2020;173:JC14.
    PubMed     Abstract available


  17. BATES ER
    Invasive therapy improved angina health status in patients with high-risk stable coronary disease and more frequent angina.
    Ann Intern Med. 2020;173:JC15.
    PubMed     Abstract available


  18. HERRINGTON WG, Staplin N
    In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
    Ann Intern Med. 2020;173:JC16.
    PubMed     Abstract available


  19. HERRINGTON WG, Staplin N
    In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
    Ann Intern Med. 2020;173:JC17.
    PubMed     Abstract available


    July 2020
  20. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Coronary Artery Calcium Score: Chalk or Cheese?
    Ann Intern Med. 2020;173:CG1.
    PubMed    


  21. MENICHELLI M, Neumann FJ, Ndrepepa G, Mayer K, et al
    Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes: Results From a Randomized Trial.
    Ann Intern Med. 2020 Jul 21. doi: 10.7326/M20-1806.
    PubMed     Abstract available


  22. CONEN D, Md PJD
    The Value of Large Randomized Trials of Two Active Interventions to Define the Optimal Treatment in Patients With Acute Coronary Syndrome.
    Ann Intern Med. 2020 Jul 21. doi: 10.7326/M20-4770.
    PubMed    



  23. Correction: Annals Consult Guys - Preventing Coronary Disease in Rheumatoid Arthritis: Do Guidelines Apply?
    Ann Intern Med. 2020;173:79.
    PubMed    


  24. KIM JH, Hammadah M, Vaccarino V, Quyyumi AA, et al
    High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients.
    Ann Intern Med. 2020;173:76-77.
    PubMed    


  25. WALTER J, Mueller C
    High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients.
    Ann Intern Med. 2020;173:77.
    PubMed    


    June 2020
  26. DUCEPPE E, Heels-Ansdell D, Devereaux PJ
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:843.
    PubMed    


  27. GUPTA N, Doshi R, Meghrajani V
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:842.
    PubMed    


  28. BHUDIA N, Bakhai A, Baumber R
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
    Ann Intern Med. 2020;172:842-843.
    PubMed    


  29. MURRAY H, Slaunwhite E
    Accelerated diagnostic algorithms with hs-cTn have >/= 92% sensitivity but lower specificity for diagnosing AMI.
    Ann Intern Med. 2020;172:JC71.
    PubMed     Abstract available


    May 2020
  30. FINUCANE TE
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2020;172:707.
    PubMed    


  31. PARK S, Han K, Kim DK
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2020;172:707-708.
    PubMed    


  32. VALLABHAJOSYULA S, Bell MR
    In unprotected left main CAD, revascularization with PCI and DES increased risk for MACCE vs CABG at 5 years.
    Ann Intern Med. 2020;172:JC55.
    PubMed     Abstract available


    April 2020
  33. BACH RG
    Low-dose colchicine after MI reduced a composite ischemic cardiovascular outcome vs placebo.
    Ann Intern Med. 2020;172:JC39.
    PubMed    


    March 2020
  34. KLOECKER DE, Davies MJ, Khunti K, Zaccardi F, et al
    Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes.
    Ann Intern Med. 2020 Mar 24. pii: 2763641. doi: 10.7326/M19-3286.
    PubMed     Abstract available


  35. VALLURUPALLI M, MacFadyen JG, Glynn RJ, Thuren T, et al
    Effects of Interleukin-1beta Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial.
    Ann Intern Med. 2020 Mar 24. pii: 2763494. doi: 10.7326/M19-2945.
    PubMed     Abstract available


  36. KHAN SU, Osman M, Khan MU, Khan MS, et al
    Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2020 Mar 17. pii: 2763089. doi: 10.7326/M19-3763.
    PubMed     Abstract available


  37. DOHERTY JU
    Combined Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Navigating Between Scylla and Charybdis.
    Ann Intern Med. 2020 Mar 17. pii: 2763091. doi: 10.7326/M20-0572.
    PubMed    


    January 2020
  38. RANASINGHE I, Hossain S, Ganesan A, Krumholz HM, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation.
    Ann Intern Med. 2020;172:166-167.
    PubMed    


  39. EMAMI M, Wong CX, Tu S, Sanders P, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation.
    Ann Intern Med. 2020;172:166.
    PubMed    


  40. SANTULLI G
    In AF and stable CAD, rivaroxaban reduced cardiovascular events and mortality more than rivaroxaban plus an antiplatelet.
    Ann Intern Med. 2020;172:JC6.
    PubMed    


  41. HUDSON M
    In suspected AMI, an extended algorithm increased sensitivity and decreased specificity for predicting 30-day MACE.
    Ann Intern Med. 2020;172:JC11.
    PubMed    


  42. RACO DL
    In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.
    Ann Intern Med. 2020;172:JC5.
    PubMed    


  43. RACO DL
    In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.
    Ann Intern Med. 2020;172:JC4.
    PubMed    


  44. CORNELL JE, Mulrow CD
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:75.
    PubMed    


  45. MAYER M
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:74.
    PubMed    


  46. KIVELA JM
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2020;172:73-74.
    PubMed    


  47. BELL KJL, Semsarian C, Doust J
    Why We Might Not Need to Stress About Ruling Out Inducible Myocardial Ischemia.
    Ann Intern Med. 2020 Jan 7. pii: 2758510. doi: 10.7326/M19-3731.
    PubMed    


  48. WALTER J, du Fay de Lavallaz J, Koechlin L, Zimmermann T, et al
    Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study.
    Ann Intern Med. 2020 Jan 7. pii: 2758509. doi: 10.7326/M19-0080.
    PubMed     Abstract available


    December 2019
  49. DUCEPPE E, Patel A, Chan MTV, Berwanger O, et al
    Preoperative N-Terminal Pro-B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery: A Cohort Study.
    Ann Intern Med. 2019 Dec 24. pii: 2758032. doi: 10.7326/M19-2501.
    PubMed     Abstract available


  50. QAMAR A, Bangalore S
    Biomarkers to Personalize Preoperative Cardiovascular Risk Stratification: Ready for Prime Time?
    Ann Intern Med. 2019 Dec 24. pii: 2758034. doi: 10.7326/M19-3718.
    PubMed    



  51. Correction: Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes.
    Ann Intern Med. 2019 Dec 17. pii: 2757635. doi: 10.7326/L19-0721.
    PubMed    


  52. DODSON JA, Hajduk AM, Geda M, Krumholz HM, et al
    Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study.
    Ann Intern Med. 2019 Dec 10. pii: 2757402. doi: 10.7326/M19-0974.
    PubMed     Abstract available


  53. KAZI DS, Bibbins-Domingo K
    Accurately Predicting Cardiovascular Risk-and Acting on It.
    Ann Intern Med. 2019 Dec 10. pii: 2757420. doi: 10.7326/M19-3662.
    PubMed    


  54. DOXEY R
    Stable Ischemic Heart Disease.
    Ann Intern Med. 2019;171:862-863.
    PubMed    


    November 2019
  55. PARK S, Lee S, Kim Y, Lee Y, et al
    Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.
    Ann Intern Med. 2019 Nov 26. pii: 2756142. doi: 10.7326/M19-0563.
    PubMed     Abstract available



  56. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status.
    Ann Intern Med. 2019 Nov 26. pii: 2756144. doi: 10.7326/P19-0016.
    PubMed    


  57. CHESKIN LJ, Slavin M
    Review: No high-certainty evidence exists that nutritional supplements or diets affect cardiovascular outcomes.
    Ann Intern Med. 2019;171:JC50.
    PubMed    


    October 2019
  58. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Preventing Coronary Disease in Rheumatoid Arthritis: Do Guidelines Apply?
    Ann Intern Med. 2019;171:CG1.
    PubMed    


  59. COHEN JB, Denker MG, Cohen DL, Townsend RR, et al
    Cardiovascular Events and Mortality in White Coat Hypertension.
    Ann Intern Med. 2019;171:603-604.
    PubMed    


  60. ZHANG ZY, Asayama K, Franklin SS, Thijs L, et al
    Cardiovascular Events and Mortality in White Coat Hypertension.
    Ann Intern Med. 2019;171:602-603.
    PubMed    


  61. BELLO NA, Miller EC, Cleary KL, Wapner R, et al
    Cases in Precision Medicine: A Personalized Approach to Stroke and Cardiovascular Risk Assessment in Women.
    Ann Intern Med. 2019 Oct 15. pii: 2753022. doi: 10.7326/M19-1601.
    PubMed     Abstract available


  62. BATES ER
    In patients with suspected AMI and LBBB, algorithms based on ECG and troponin data were tested to rule MI in or out.
    Ann Intern Med. 2019;171:JC47.
    PubMed    


  63. BATES ER
    In suspected MI without ST elevation, a risk tool including hs-cTnI or hs-cTnT predicted diagnosis and 30-d outcomes.
    Ann Intern Med. 2019;171:JC46.
    PubMed    


    September 2019
  64. SELAK V, Jackson R, Poppe K, Wu B, et al
    Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis.
    Ann Intern Med. 2019 Sep 17. pii: 2751452. doi: 10.7326/M19-1132.
    PubMed     Abstract available


    August 2019
  65. KATZ D, Gavin MC
    Stable Ischemic Heart Disease.
    Ann Intern Med. 2019;171:ITC17-ITC32.
    PubMed     Abstract available


    July 2019
  66. RANASINGHE I, Labrosciano C, Horton D, Ganesan A, et al
    Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study.
    Ann Intern Med. 2019 Jul 30. pii: 2739788. doi: 10.7326/M18-2810.
    PubMed     Abstract available


  67. O'BRIEN CW, Juraschek SP, Wee CC
    Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey.
    Ann Intern Med. 2019 Jul 23. pii: 2738925. doi: 10.7326/M19-0953.
    PubMed    


  68. VALLABHAJOSYULA S, Bell MR
    Immediate and delayed coronary angiography did not differ for survival after OHCA without STEMI.
    Ann Intern Med. 2019;171:JC4.
    PubMed    


  69. PANAGIOTOU OA, Kumar A, Gutman R, Keohane LM, et al
    Hospital Readmission Rates in Medicare Advantage and Traditional Medicare: A Retrospective Population-Based Analysis.
    Ann Intern Med. 2019;171:99-106.
    PubMed     Abstract available


  70. KHAN SU, Khan MU, Riaz H, Valavoor S, et al
    Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes: An Umbrella Review and Evidence Map.
    Ann Intern Med. 2019 Jul 9. pii: 2737825. doi: 10.7326/M19-0341.
    PubMed     Abstract available


  71. YEBYO HG, Aschmann HE, Puhan MA
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:74-76.
    PubMed    


  72. DJULBEGOVIC B, Hozo I
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:73-74.
    PubMed    


  73. ZHOU Z
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:73.
    PubMed    


  74. SPENCE JD
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:72-73.
    PubMed    


  75. SORUM PC
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:74.
    PubMed    


  76. GOOD CB, Hernandez I, Parekh N
    Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2019;171:72.
    PubMed    


    June 2019
  77. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Length of Stay After Myocardial Infarction: How Low Can We Go?
    Ann Intern Med. 2019;170:CG1.
    PubMed    


  78. CENTOR RM, Blaha MJ
    Web Exclusive. Annals On Call - Coronary Artery Calcium Testing.
    Ann Intern Med. 2019;170:OC1.
    PubMed    


  79. BATES ER
    After an acute coronary syndrome, alirocumab reduced total nonfatal CV events and deaths vs placebo.
    Ann Intern Med. 2019;170:JC62.
    PubMed    


  80. KIRSCHNER JM, Hunter BR
    In normoxemic suspected MI, oxygen therapy did not reduce all-cause mortality or HF hospitalization at 2 years.
    Ann Intern Med. 2019;170:JC63.
    PubMed    


  81. COHEN JB, Lotito MJ, Trivedi UK, Denker MG, et al
    Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2019 Jun 11. pii: 2735719. doi: 10.7326/M19-0223.
    PubMed     Abstract available


  82. GRUNDY SM, Stone NJ
    2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.
    Ann Intern Med. 2019;170:779-783.
    PubMed     Abstract available


    May 2019
  83. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Cardiovascular Risk, Blood Pressure, and Cognition in a Patient With Diabetes.
    Ann Intern Med. 2019;170:CG1.
    PubMed    


  84. SCHECTMAN JM
    Review: In adults, general health checks do not reduce all-cause, cardiovascular, or cancer mortality.
    Ann Intern Med. 2019;170:JC52.
    PubMed    


    April 2019
  85. BRAND A, Gao L, Hamann A, Crayen C, et al
    Medical Graphic Narratives to Improve Patient Comprehension and Periprocedural Anxiety Before Coronary Angiography and Percutaneous Coronary Intervention: A Randomized Trial.
    Ann Intern Med. 2019 Apr 9. pii: 2730521. doi: 10.7326/M18-2976.
    PubMed    


    March 2019
  86. AVIV A
    Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer.
    Ann Intern Med. 2019;170:356.
    PubMed    


  87. O'GLASSER AY
    Regarding Marcia.
    Ann Intern Med. 2019;170:346-347.
    PubMed    


    February 2019
  88. SELAK V, Jackson R, Poppe K, Wu B, et al
    Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study.
    Ann Intern Med. 2019 Feb 26. pii: 2726667. doi: 10.7326/M18-2808.
    PubMed     Abstract available


  89. LU J, Lu Y, Yang H, Bilige W, et al
    Characteristics of High Cardiovascular Risk in 1.7 Million Chinese Adults.
    Ann Intern Med. 2019 Feb 19. pii: 2725144. doi: 10.7326/M18-1932.
    PubMed     Abstract available


  90. WHELTON PK, Colantonio LD
    Cardiovascular Disease Risk Estimation in China.
    Ann Intern Med. 2019 Feb 19. pii: 2725146. doi: 10.7326/M18-3301.
    PubMed    


  91. BELL KJL, Doust J, Glasziou P, Cullen L, et al
    Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?
    Ann Intern Med. 2019;170:259-261.
    PubMed    


  92. KAZI DS, Penko J, Coxson PG, Guzman D, et al
    Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial.
    Ann Intern Med. 2019;170:221-229.
    PubMed     Abstract available


  93. CARDOSO R, Nasir K, Blumenthal RS, Blaha MJ, et al
    Selective Use of Coronary Artery Calcium Testing for Shared Decision Making: Guideline Endorsed and Ready for Prime Time.
    Ann Intern Med. 2019 Feb 12. pii: 2724340. doi: 10.7326/M18-3675.
    PubMed    


    January 2019
  94. JORGE A, Wallace ZS, Lu N, Zhang Y, et al
    Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study.
    Ann Intern Med. 2019 Jan 22. pii: 2722549. doi: 10.7326/M18-1570.
    PubMed     Abstract available


  95. MERLI GJ, Weitz HH
    Web Exclusive. Annals Consult Guys - Low Risk for Postoperative Myocardial Infarction: What Do We Really Know?
    Ann Intern Med. 2019;170:CG1.
    PubMed    


  96. GOODMAN M, Getahun D, Silverberg MJ, Safer J, et al
    Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.
    Ann Intern Med. 2019;170:143.
    PubMed    


  97. GOLDSTEIN Z, Streed C, Resiman T, Mukherjee M, et al
    Cross-Sex Hormones and Acute Cardiovascular Events in Transgender Persons.
    Ann Intern Med. 2019;170:142-143.
    PubMed    


  98. FURLAN S, Borzak S
    After PCI with 2nd-generation DESs for STEMI, dual-antiplatelet therapy for 6 mo was noninferior to 12 mo.
    Ann Intern Med. 2019;170:JC6.
    PubMed    


  99. SULLIVAN K, Van Spall HGC
    A wearable cardioverter-defibrillator did not reduce arrhythmic death in MI with reduced ejection fraction.
    Ann Intern Med. 2019;170:JC5.
    PubMed    


  100. THOMAS NJ
    Physician, Heal Thyself.
    Ann Intern Med. 2019;170:135.
    PubMed    


  101. KAUFMAN TM, Fazio S, Shapiro MD
    Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?
    Ann Intern Med. 2019 Jan 8. pii: 2720158. doi: 10.7326/M18-3009.
    PubMed    


    December 2018
  102. HUDSON MP
    Coronary CTA reduced risk for coronary events at 5 years in patients with stable chest pain.
    Ann Intern Med. 2018;169:JC70.
    PubMed    


  103. GILBERT MP, Bain SC, Franek E, Jodar-Gimeno E, et al
    Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.
    Ann Intern Med. 2018 Dec 4. pii: 2717732. doi: 10.7326/M18-1569.
    PubMed    


  104. YEBYO HG, Aschmann HE, Puhan MA
    Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Ann Intern Med. 2018 Dec 4. pii: 2717730. doi: 10.7326/M18-1279.
    PubMed     Abstract available



  105. Benefits and Harms of Using Statins to Prevent Cardiovascular Disease.
    Ann Intern Med. 2018 Dec 4. pii: 2717123. doi: 10.7326/P18-0019.
    PubMed    


    November 2018
  106. BATES ER
    Review: In coronary artery disease, PCI reduces 30-day and 5-year risk for stroke compared with CABG.
    Ann Intern Med. 2018;169:JC55.
    PubMed    


  107. SMITH DA
    Review: In adults, increasing omega-6 fatty acid intake does not reduce mortality or overall cardiovascular events.
    Ann Intern Med. 2018;169:JC51.
    PubMed    


  108. SMITH DA
    Review: Long-chain omega-3 fatty acids have no effect on mortality or overall cardiovascular events.
    Ann Intern Med. 2018;169:JC50.
    PubMed    


  109. CENTOR RM, Hayward RA
    Web Exclusive. Annals On Call - Improving Estimation of Cardiovascular Risk.
    Ann Intern Med. 2018;169:OC1.
    PubMed    


  110. DEVEREAUX PJ
    The Potential for Troponin to Inform Prognosis in Patients With Stable Coronary Artery Disease.
    Ann Intern Med. 2018 Nov 6. pii: 2712931. doi: 10.7326/M18-2984.
    PubMed    


  111. HAMMADAH M, Kim JH, Tahhan AS, Kindya B, et al
    Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study.
    Ann Intern Med. 2018 Nov 6. pii: 2712482. doi: 10.7326/M18-0670.
    PubMed     Abstract available


    October 2018
  112. GROSSO G, Sippl N, Kjellstrom B, Amara K, et al
    Antiphospholipid Antibodies in Patients With Myocardial Infarction.
    Ann Intern Med. 2018 Oct 23. pii: 2709123. doi: 10.7326/M18-2130.
    PubMed    


    August 2018

  113. Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors.
    Ann Intern Med. 2018;169:270-271.
    PubMed    


  114. MAI LM, Oczkowski W
    Tenecteplase before thrombectomy for ischemic stroke improved reperfusion compared with alteplase.
    Ann Intern Med. 2018;169:JC20.
    PubMed    


    July 2018
  115. LIU P, Dhruva SS, Shah ND, Ross JS, et al
    Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.
    Ann Intern Med. 2018 Jul 24. pii: 2694805. doi: 10.7326/M18-0965.
    PubMed    


  116. GETAHUN D, Nash R, Flanders WD, Baird TC, et al
    Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
    Ann Intern Med. 2018 Jul 10. pii: 2687653. doi: 10.7326/M17-2785.
    PubMed     Abstract available


  117. STUART JJ, Tanz LJ, Missmer SA, Rimm EB, et al
    Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study.
    Ann Intern Med. 2018 Jul 3. pii: 2686987. doi: 10.7326/M17-2740.
    PubMed     Abstract available


  118. FRASER A
    Women's Cardiovascular Health After a Hypertensive Disorder of Pregnancy.
    Ann Intern Med. 2018 Jul 3. pii: 2686988. doi: 10.7326/M18-1443.
    PubMed    



  119. High Blood Pressure During Pregnancy and Development of Risk Factors for Cardiovascular Disease.
    Ann Intern Med. 2018 Jul 3. pii: 2686989. doi: 10.7326/P18-0008.
    PubMed    


    June 2018
  120. BATES ER
    Review: In CAD, CABG reduced 5-year mortality more than PCI in multivessel but not left main disease.
    Ann Intern Med. 2018;168:JC66.
    PubMed    


  121. DEFILIPPIS AP, Trainor P
    When Given a Lemon, Make Lemonade: Revising Cardiovascular Risk Prediction Scores.
    Ann Intern Med. 2018 Jun 5. pii: 2683614. doi: 10.7326/M18-1175.
    PubMed    


  122. YADLOWSKY S, Hayward RA, Sussman JB, McClelland RL, et al
    Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk.
    Ann Intern Med. 2018 Jun 5. pii: 2683613. doi: 10.7326/M17-3011.
    PubMed     Abstract available


    May 2018
  123. EBERT BL, Libby P
    Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers.
    Ann Intern Med. 2018 May 29. pii: 2683000. doi: 10.7326/M18-0737.
    PubMed    


  124. STAMATELOPOULOS K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, et al
    Amyloid-beta (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.
    Ann Intern Med. 2018 May 22. pii: 2681795. doi: 10.7326/M17-1540.
    PubMed     Abstract available


  125. GOEL A
    Efficacy and safety of ticagrelor were similar in patients with past MI, regardless of multivessel coronary disease.
    Ann Intern Med. 2018;168:JC56.
    PubMed    


  126. PERZYNSKI AT, Rothberg MB, Dawson NV, Coulton CJ, et al
    Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position.
    Ann Intern Med. 2018;168:681-682.
    PubMed    


  127. SPENCE JD
    Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position.
    Ann Intern Med. 2018;168:680-681.
    PubMed    


    April 2018
  128. CHAMBERLAIN JJ, Johnson EL, Leal S, Rhinehart AS, et al
    Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.
    Ann Intern Med. 2018 Apr 3. pii: 2677350. doi: 10.7326/M18-0222.
    PubMed     Abstract available


    March 2018
  129. BROWN AF, Liang LJ, Vassar SD, Escarce JJ, et al
    Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014.
    Ann Intern Med. 2018 Mar 20. pii: 2675356. doi: 10.7326/M17-0996.
    PubMed     Abstract available


  130. MENSAH GA
    The Black-White Cardiovascular Health Disparity Is Narrowing, But Not for the Reason You Think.
    Ann Intern Med. 2018 Mar 20. pii: 2675357. doi: 10.7326/M18-0349.
    PubMed    


    February 2018
  131. GRANT PJ, Eagle KA
    Annals for Hospitalists Inpatient Notes - Perioperative Medicine-The Past, Present, and Future of Cardiovascular Risk Assessment and Risk Reduction Strategies.
    Ann Intern Med. 2018;168:HO2-HO3.
    PubMed    


    January 2018
  132. RAVI D, Ghasemiesfe M, Korenstein D, Cascino T, et al
    Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes: A Systematic Review.
    Ann Intern Med. 2018 Jan 23. pii: 2670319. doi: 10.7326/M17-1548.
    PubMed     Abstract available


  133. MANCINI GBJ
    Comparison Shopping: Guidelines for Statins for Primary Prevention of Cardiovascular Disease.
    Ann Intern Med. 2018 Jan 2. pii: 2667697. doi: 10.7326/M17-2917.
    PubMed    


    December 2017
  134. LIPSCOMBE LL
    Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes.
    Ann Intern Med. 2017;167:JC67.
    PubMed    


  135. SUNDARARAJAN V, Vogrin S
    Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.
    Ann Intern Med. 2017;167:836.
    PubMed    


  136. OSHIMA Y, Morishima Y, Ono K, Hirano M, et al
    Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.
    Ann Intern Med. 2017;167:836.
    PubMed    


  137. KOPIN L, Lowenstein C
    Dyslipidemia.
    Ann Intern Med. 2017;167:ITC81-ITC96.
    PubMed     Abstract available


    November 2017
  138. O'DONOGHUE FJ, McDonald CF
    Review: In obstructive sleep apnea, continuous positive airway pressure does not reduce cardiovascular outcomes.
    Ann Intern Med. 2017;167:JC55.
    PubMed    


  139. O'DONOGHUE FJ, McDonald CF
    Review: In adults with sleep apnea, positive airway pressure does not reduce cardiovascular events or death.
    Ann Intern Med. 2017;167:JC54.
    PubMed    


  140. PICCOLO R, Windecker S
    Low-Dose Aspirin to Reduce the Risk for Myocardial Infarction Among Patients With Coronary Stents Undergoing Noncardiac Surgery.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2954.
    PubMed    


  141. GRAHAM MM, Sessler DI, Parlow JL, Biccard BM, et al
    Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2341.
    PubMed     Abstract available


  142. NIEUWSMA JA, Williams JW Jr, Namdari N, Washam JB, et al
    Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression: A Systematic Review.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-1811.
    PubMed     Abstract available


  143. DAVIDSON KW, Wasson LT, Kronish IM
    Should You Screen for and Manage Depression in Patients With a Recent Acute Coronary Syndrome? Evidence-Based Answers.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2831.
    PubMed    


  144. GO AS, Singer DE, Toh S, Cheetham TC, et al
    Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M16-1157.
    PubMed     Abstract available


  145. ZHANG XL, Zhu QQ, Kang LN, Li XL, et al
    Mid- and Long-Term Outcome Comparisons of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2017;167:642-654.
    PubMed     Abstract available


    October 2017

  146. Correction: Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection.
    Ann Intern Med. 2017;167:528.
    PubMed    


    September 2017
  147. DHARMARAJAN K, McNamara RL, Wang Y, Masoudi FA, et al
    Age Differences in Hospital Mortality for Acute Myocardial Infarction: Implications for Hospital Profiling.
    Ann Intern Med. 2017 Sep 26. doi: 10.7326/M16-2871.
    PubMed     Abstract available


  148. BAKER DW
    Age-Related Differences in Hospital Quality of Care for Acute Myocardial Infarction: Getting to the Heart of the Matter.
    Ann Intern Med. 2017 Sep 26. doi: 10.7326/M17-2363.
    PubMed    


  149. QUINN T
    Review: Real-world use of nonsteroidal antiinflammatory drugs is associated with acute myocardial infarction.
    Ann Intern Med. 2017;167:JC30.
    PubMed    


  150. WORSTER A, Kavsak P
    4 hs-cTnI algorithms had high sensitivity and low failure rates for ruling out acute MI in the ED.
    Ann Intern Med. 2017;167:JC35.
    PubMed    


  151. WORSTER A, Kavsak P
    High-STEACS Algorithm missed fewer patients with acute MI than the ESC Pathway in the ED.
    Ann Intern Med. 2017;167:JC34.
    PubMed    


  152. LOWENSTERN A, Newby LK
    In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin + clopidogrel reduced adverse events.
    Ann Intern Med. 2017;167:JC28.
    PubMed    


    August 2017
  153. RYMER JA, Granger CB
    Review: A single hs-cTnT with a cutpoint < limit of detection plus a nonischemic ECG can rule out acute MI.
    Ann Intern Med. 2017;167:JC23.
    PubMed    


    July 2017
  154. SCHATTNER A
    Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure.
    Ann Intern Med. 2017;167:JC8.
    PubMed    


    April 2017
  155. KUSSMAUL III WG
    The Single High-Sensitivity Serum Cardiac Troponin Level: A Significant Advance for Chest Pain Pathways?
    Ann Intern Med. 2017 Apr 18. doi: 10.7326/M17-0919.
    PubMed    


    February 2017
  156. BATES ER
    In left main CAD, PCI with everolimus-eluting stents was noninferior to CABG for death, MI, or stroke at 3 years.
    Ann Intern Med. 2017;166:JC21.
    PubMed    


  157. BATES ER
    In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI.
    Ann Intern Med. 2017;166:JC20.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: